Pila Pharma AB (FRA:5KC) Net Margin %: -4,692.00% (As of Dec. 2025)


FRA:5KC Pila Pharma AB FRA:5KC
49 GF Score
Price €0.10
GF Value €0.15
! 3 Warning Signs
View Full Analysis

What is Pila Pharma AB Net Margin %?

Pila Pharma AB FRA:5KC -3.24% 49 Net Margin % is -4,692.00% as of Dec. 2025. GuruFocus rates FRA:5KC with a GF Score™ of 49/100 and a GF Value™ of €0.15. The stock has 3 warning signs investors should review. Among 940 Biotechnology companies, Pila Pharma AB ranks worse than 82.45% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Pila Pharma AB's Net Income for the six months ended in Dec. 2025 was €-1.17 Mil. Pila Pharma AB's Revenue for the six months ended in Dec. 2025 was €0.03 Mil. Therefore, Pila Pharma AB's net margin for the quarter that ended in Dec. 2025 was -4,692.00%.

The historical rank and industry rank for Pila Pharma AB's Net Margin % or its related term are showing as below:

FRA:5KC' s Net Margin % Range Over the Past 10 Years
Min: -2505.49   Med: -1479.53   Max: -678.74
Current: -1496.27

FRA:5KC's Net Margin % is ranked worse than
82.45% of 940 companies
in the Biotechnology industry
Industry Median: -88.295 vs FRA:5KC: -1496.27

Pila Pharma AB  (FRA:5KC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Pila Pharma AB Net Margin % Related Terms

Pila Pharma AB Net Margin % Historical Data

* Premium members only.

The historical data trend for Pila Pharma AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pila Pharma AB Net Margin % Chart

Pila Pharma AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial -2,392.86 -1,424.56 -677.86 -1,458.21 -1,501.92

Pila Pharma AB Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -766.67 -613.56 -6,911.11 -483.12 -4,692.00

FRA:5KC vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Pila Pharma AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pila Pharma AB Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's Net Margin % falls into.


FRA:5KC
49GF Score
Pila Pharma AB FRA:5KC
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pila Pharma AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pila Pharma AB's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.562/0.104
=-1,501.92 %

Pila Pharma AB's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.173/0.025
=-4,692.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -4,692.00% mean?
Pila Pharma AB (FRA:5KC) has a Net Margin % of -4,692.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Pila Pharma AB and its competitors. According to the industry distribution chart, Pila Pharma AB ranks #775 out of 940 companies in the Biotechnology industry, placing it in the top 82.4%.
Is Pila Pharma AB's Net Margin % too high?
Pila Pharma AB's current Net Margin % is -4,692.00%. Based on the distribution chart, Pila Pharma AB ranks #775 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pila Pharma AB has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Pila Pharma AB's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pila Pharma AB ranks #775 out of 940 companies for Net Margin %. This places Pila Pharma AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Pila Pharma AB and its competitors. Pila Pharma AB's current Net Margin % is -4,692.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pila Pharma AB stock overvalued right now?
Pila Pharma AB (FRA:5KC) has a current Net Margin % of -4,692.00%. The stock's GF Value™ is €0.15, compared to a current price of €0.10 — trading 30.3% below its estimated fair value. The current Net Margin % is -4,692.00%. Pila Pharma AB's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Pila Pharma AB (FRA:5KC), the current Net Margin % is -4,692.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pila Pharma AB (FRA:5KC) Overvalued in 2026?

Based on GuruFocus' analysis, Pila Pharma AB stock appears to be undervalued. The current stock price of €0.10 is trading 30.3% below its estimated GF Value™ of €0.15.

Key valuation signals for FRA:5KC:

  • Net Margin %: -4,692.00%
  • GF Value™: €0.15 vs. price of €0.10 (30.3% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the FRA:5KC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pila Pharma AB Business Description

Other Exchanges PILA:Sweden
Address Norra Vallgatan 72, Malmo, SWE, 211 21
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
49GF Score

Get the complete analysis for FRA:5KC

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.15
GF Value